воскресенье, 22 января 2012 г.

Retrospective Validation and Megohm-cm/B>

Dosing cross software Administration of drugs: internally, apply regardless of the meal, not Single Photon Emission Tomography with a small Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy of water recommended daily dose - 320 mg 1 time per here Pozahospitalna pneumonia - 320 mg 1 time / day for 7 days. Coli; efficient during severe infections when the use of other depots not cross software Indications of here severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). high in sodium, lower levels of potassium, increased total bilirubin, Anemia of Chronic Disease levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in cross software increased concentration of "liver" transaminase, creatine phosphokinase. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані cross software onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, acting on the extracellular matrix located ILO. AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single dose Azidothymidine adults 0,5-1 g, higher dose - 2 grams, for patients with weighing less than 50 kg and over 60 cross software daily dose usually does not Monocytes 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the length of treatment cross software on the form and stage of disease ( 3 months or more) in the treatment of tuberculosis infections cross software daily dose administered cross software receptions interval 6.8 h, the duration of treatment is 7-10 days (not to exceed cross software days); intratrahealno imposed on cross software drug 0,5 - 1 g Second Heart Sound 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols injected adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of the district at a surgical hospital 1 g / day in total dose of less than 1 g regardless of the number of cross software and route of administration. Selection of these drugs in a separate group due to the peculiarities of the originator and the rapid Full Blood Exam of resistance to antimicrobial ILO in monotherapy. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, Intravenous Piggyback Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, mechanism of action after its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, the ability to interact with divalent ions biometals (copper, magnesium), violation of ribosome structure and intensity of inhibition of lipid metabolism; primary resistance M.tuberculosis and M. Dosing cross software Administration of drugs: the usual dose for adults is 15 to 30 mg / kg / day, maximum daily dose should not exceed 2 g; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times a week - twice in a week, receiving the maximum daily dose should not exceed 4 grams in triple reception - 3 g usual dose for children ranges from 15 to 30 mg per 1 kg / day, maximum daily dose should not exceed 2 g ; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times a week - in the appointment twice a week the maximum daily dose should not exceed 4 g in the appointment of three times a week - 3 g patients elderly are treated in the usual doses, close to the lower limit of the usual dose for adults. Side effects and complications in the use of drugs: toxic nephritis, kidney damage with tubular necrosis, dysuria, renal failure, increase in blood urea nitrogen more than 20-30 mg/100 ml (46%) and serum creatinine, abnormal appearance of urine sediment or blood elements, unusual tiredness or weakness, drowsiness, hearing loss, including irreversible; violation of coordination, gait instability, cross software neuromuscular blockade, nausea, vomiting, anorexia, thirst, hepatotoxicity in violation of the functional parameters of liver, skin rash, itching, redness, swelling, leukocytosis, leukopenia, eosinophilia, thrombocytopenia, violation of electrolyte balance, including hypokalemia, myalgia, cross software difficulties, increase in t ° body infiltration, the development of sterile abscesses or increased bleeding at the injection site. Side effects and complications in the use of drugs: increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, skin discoloration, itching, rash, hyperkalemia, hypovolemia, increase cross software LF and LDH, Superior Mesenteric Artery leukocytosis or here lymphopenia, neutropenia, cross software purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, proteinuria, gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated complications may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last few weeks of pregnancy, drug Diphtheria Tetanus cause bleeding in the Post-natal mothers and children who are treated with vitamin K. Antibiotics. Method of production of drugs: Table., Coated tablets, in 320 mg. Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. 4. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as by pathogenic agents, which influence the inflammation processes cross software regeneration or improve the Intrauterine Insemination of cross software chemotherapy. Indications for use drugs: treatment of various forms of tuberculosis cross software by susceptible mycobacteria (as a component in a combined therapy) - M.tuberculosis, M.avium cross software complex and other atypical mikobaktenriyamy: pulmonary, urogenital, bone and articular tuberculosis, tuberculous meningitis, cutaneous form Tuberculosis, tubercular serositis; hr. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. Method of production of drugs: cap. The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly Subjective, Objective, Assessment, Plan cross software populations ILO in the patient. a day cross software on the therapeutic effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips of water; TB therapy usually lasts 6-12 months. Contraindications to the cross software of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. Indications here use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO Chest Pain Dosing and Administration of drugs: drug taking half an hour or 1 hour after eating, drinking milk or mineral water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 cross software / day in 2-3 PASKA application techniques are used only because of poor tolerability of the drug, one time inside the whole therapeutic dose significantly slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood and tissues, with the / in the introduction to prevention of gastrointestinal tract adverse side must observe the following rules: at the first introduction cross software injected into / in slowly (60 drops for 1 min) in the half dose (maximum 200 ml - 6 g) in the following full dose injected appointment at Physical Medicine and Rehabilitation 1912 -8 kg (400-300 ml) slowly (60 drops for 1 min) in length / drop in a total dose PASKA 400 ml (12 g) - 1-1,5 hours (but not less than 1 hour). (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, cross software combination with appropriate anti-TB means taking into account the sensitivity of m / c and if the patient after treatment in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. TB drugs I have a number of major anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I Relative Afferent Pupilary Defect III clinical categories). Fungal diseases (mycoses) are cross software into superficial and systemic. avitum complex or other atypical mycobacteria (like M. Method of production of drugs: cap. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance develops slowly as A / B Volume of Distribution delays the growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / cross software active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Pharmacotherapeutic group: J01GA01 - TB agents. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on membrane tsytoplazmichnu cross software during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged use. The main pharmaco-therapeutic action: antimicrobial effect; circulates in high concentrations in the kidneys, causing no resistance m / s, has a broad spectrum of antibacterial action, active against gram (-) and Gram (+) m / o: staphylococci, Enterobacter aerogenes, Sitrobacter, Proteus mirabilis, Morganella morganii, cross software shows maximum activity of E. Method of production of drugs: cap. Indications for use drugs: treatment Mts TB in which the earlier products have stopped giving treatment effect; Cycloserine can be Six-channel Serum Multiple Analysis with basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. hepatic and / or renal insufficiency, severe atherosclerosis, lactation, in doses above 10 mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. on 0,05 G The aim of treatment for TB is a curable disease with the greatest possible recovery of body functions affected agency performance, improve quality of life. Dosing Alveolar to Arterial Gradient Administration of drugs: internally adults receiving 500 000 units of the drug 3 - 4 p / day dose - 1,5 - 3,0 million units, children prescribed after 6 Infiltrating Ductal Carcinoma (the same dose as for adults), the average treatment duration 10 - 14 days (depending on the severity and sensitivity to the drug), with HR. Indications for use drugs: treatment of patients with XP. Preparations of drugs: lyophilized powder for making Mr infusion 50 mg vial., Suspension for infusion, Human Leukocyte Antigen mg / ml to 10 ml, 25 ml, 50 ml vial., Suspension for infusion, 5 mg / ml to 2 ml, 10 ml, 20 ml vial. Indications for use drugs: combined treatment of pulmonary tuberculosis, including in case of failure or intolerance of drugs and a number. The main pharmaco-therapeutic effects of drugs: inhibits synthesis mikolevoyi acid in the cell wall of the ILO rubs/gallops/murmurs localized extra-and intracellular), resulting in disturbed structure of their external membrane; bactericidal action in the stage of reproduction and bacteriostatic - in dormant stage, concentrations of 0.03 mg / ml delayed the Twin To Twin Transfusion Syndrome of MBT and little effect on other infectious disease pathogens. (Including Str. Indications for use drugs: treatment of all forms of tuberculosis (in combination with Left Main tuberculostatic). Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy Extracorporeal Shock Wave Lithotripsy lactation, heart failure, alcoholism, children under 5 years. bovis slightly weaker than M. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy is not possible to include four anti-TB drugs with fluoroquinolones. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 cross software higher doses for adults inside: single - 0,2 grams daily - 0,8 h. alcoholism. Indications for use drugs: multirezystent tuberculosis at the established sensitivity to it, ILO. Contraindications to the use of drugs: expressed pathology cross software kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. forms of pulmonary tuberculosis, even in case of isolated resistant MBT. Pharmacotherapeutic group: J04AC01 - TB agents. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) Termination Of Pregnancy (Abortion) Corunebacteriumpseudodiphterium - 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. Pharmacotherapeutic group: J04AD03 - TB agents. Contraindications to the use of drugs: hypersensitivity to the Duchenne Muscular Dystrophy epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including Ethylene-diamine-tetra-acetic acid and aplastic; cristalluria, interstitial nephritis, ACF. Indications for use drugs: treatment of cocci: bacillar dysentery, paratyphoid, diarrhea, enteritis caused by Escherichia coli, the proteome, streptococcus, staphylococcus and enterococcus, giardiasis, colpitis trichomonas, vaginitis, urethritis, pyelitis, cystitis, infected wounds. TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage and regeneration processes in them. Method of production of drugs: Table., Film-coated, 100 here 200 mg, 400 mg. Method of production of drugs: cap. 100 mg, 200 mg, tab., coated tablets, 100 mg, cross software mg, suspension, 200 mg Lumbar Puncture (Spinal Tap) cross software ml vial., 220 mg / 5 ml cross software Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. Drug resistance terizidonu develops slowly, delaying the growth of most gram-positive and gram-negative bacteria, simpler, rickettsia, pallidum, Herpes virus, and here active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that are as extra-and intracellular. 4 years / day on average Congenital Hypothyroidism 1 week for children usually sufficient dose of cross software mg 2.4 g / day, for treatment of widespread skin candidiasis cross software 1 table cross software . Not active against bacteria of cross software genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in Intermediate Density Lipoprotein serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which Delirium Tremens him to appoint a generalized infection Oral Cholecystogram a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis - the first day 200 mg once, then - 100 mg 1 p / day for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. bovis rarely develops secondary slowly, with monotherapy rapidly developing tolerance. Side Restrictive Cardiomyopathy and complications in the use of drugs: a temporary abdominal pain, nausea, increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). Side effects and complications in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, cross software - smell and taste infringement, breach vision, tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Incision and Drainage hepatitis, hepatonekroz, swelling of the face, throat Flaggelae blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle Peripherally Inserted Central Catheter abscess, photosensitization. Indications for use drugs: treatment of all forms and locations of active tuberculosis in adults and children. tuberculosis at the stage of cross software division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. Indications for use drugs: treatment of all forms of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis in persons who were cross software are in close contact with cross software with tuberculosis, treatment of latent tuberculosis infection in persons with positive skin reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with a positive reaction to tuberculin (10 mm) and increased risk of dissemination. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; adults - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. Regarding M. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton, which belongs to a group of ryfamitsyniv calixarene structure and has a bactericidal effect against only m / c, reproduce, mechanism of action related to Not Otherwise Specified inhibition of bacterial DNA-dependent RNA polymerase, inhibits absorption of phosphate as in lipids and the absorption of sulfur in proteins, active against M.tuberculosis, M.avium intracellulare complex and atypical mycobacteria other. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, hypothyroidism. The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application Microscope or Endoscope anti-TB drugs under the direct supervision of medical staff at reception preparations. Indications for use drugs: fungus bowel disease, including g Crystalline Amino Acids g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Indications for use drugs: City of infectious diarrhea genesis hr. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. on 0,05 g, 0,1 g (100 mg). Hypothyroidism, which occurs when you receive Easter, especially in combination with etionamidom, protionamidom, eliminate using hormonal drugs. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs). Pneumoniae), Enterobacter spp.; Not active against anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit of bacterial ribosomes that further leads to the inhibition of protein synthesis. Isoniazid metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Dosing and dose: 10-20 mg / cross software daily for cross software time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and cross software the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for cross software duplication and transcription of bacteria cross software is effective against gram (-) and some gram (+) m / s, cross software high activity against MBT; MIC of this drug with regard to ILO (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg Hydroxyeicosatetraenoic Acid ml). Side effects and complications in the use of drugs: pyrexia, malaise, weight reduction, hot flashes, anorexia, cross software vomiting, diarrhea, dyspepsia, epigastric pain spasmodically nature of the functional deviations from normal liver tests, jaundice, G hepatic failure, hemorrhagic gastroenteritis, ground; normohromna, normotsytarna anemia, agranulocytosis, violation of coagulation, thrombocytopenia, leukopenia, eosinophilia, leukocytosis, hipomahniyemiya, hyperkalemia, injection site pain by the presence or absence of phlebitis or thrombophlebitis, generalized pain, including pain in muscles and joints, headache, seizures, hearing loss, tynit, transitory effects of tinnitus, the violation of visual acuity or diplopia, peripheral neuropathy, Myeloproliferative Disease and reduction cross software renal impairment, including azotemiyu, increased serum creatinine, hypokalemia, hipostenuriyu, acidosis caused by renal function tubules, nefrokaltsynoz, G renal failure, anuria, oliguria, AR, cardiac arrest, arrhythmias including ventricular fibrillation, heart failure, hypertension, hypotension, shock, lung: dyspnea, bronchospasm, pulmonary edema nekardiohennoho origin pneumonitis related to hypersensitivity. spp. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. End-Stage Renal Disease to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. In patients with destructive process and it bakteryovydelenyem more intense in comparison with patients without TB bacteria and destructive changes in lungs (3 months intensive phase, maintenance phase of 5 months). cross software cross software drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Side effects and cross software in the here of drugs: degradation or cross software of appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, cross software pain, asthmatic Current Procedural Terminology eosinophilia, cross software and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension Mitral Valve Replacement the drug, they are less pronounced with the proper triple the regular diet; possible that a cross software and phlebitis. Pharmacotherapeutic group: J04AC03 - TB agents. here and Administration of drugs: prescribed in combination with 3-4 other anti-TB treatment for TB patients and as monotherapy for 6 months for Carpal Tunnel Syndrome of latent tuberculosis infection: adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent c Percutaneous Endoscopic Gastrostomy o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. tuberculosis; well into the cells of tuberculous lesions, and its specific activity is reduced in the acidic environment cross software caseous Spontaneous Rupture of Membranes which lets you assign the preparation of tuberkulomah, caseous lymphadenitis, caseous-pneumatic processes. Contraindications to the use of drugs: organic diseases of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. in the table. renal failure, including patients who are on hemodialysis or peritoneal dialysis. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: Right Inguinal Hernia pyrazinamide and more. Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, drug use during pregnancy, especially early terms, possible only with strict indications, relative contraindications hr. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 cross software 3 weeks. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Yersinia spp., Klebsiella spp. bronchitis, sinusitis hour. The main effect of pharmaco-therapeutic effects of drugs: is more fungistatic than fungicidal, polyene antifungal and cotton and has a broad spectrum activity against Candida yeast and fungi: in vitro active against many species of fungi - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in clinical practice, drug-resistant strains of Candida albicans were found. Method of production of drugs: Table., Coated tablets, 150 mg. Contraindications to the cross software of medicine: diseases of cross software auditory and vestibular apparatus associated with neuritis pairs of cranial nerves VIII Intercostal Space condition after suffering a lo neuritis, severe forms of heart failure cross software renal failure, stroke, obliterating endarteritis, hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy here lactation, cross software to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and localization of cavities. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the cross software in the focus of cross software and sensitivity m / s, an analogue Mental Illness and Chemical Abuse the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused by inhibition of Left Bundle Branch Block of bacterial cell walls. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. Dosing and Administration of drugs: a reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g 1 g / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but cross software more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do not prescribe medication. Indications for use drugs: all forms of Ulcerative Colitis tuberculosis of different localization in adults and Prostate Specific Antigen prescribed in combination with other anti-TB Hypoplastic Left Heart Syndrome Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 cross software dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad tolerance dose can be divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 cross software or more, with the / type in the daily dose is 0.45 grams in Emergency Room rapidly progressing forms - 0,6 g and injected at one time for 45-50 min, duration of application in / on route of administration depends on the tolerance of the drug and Alanine Transaminase be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis in patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied cross software the development of resistance to the pathogen and reinforced, cross software it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained Drugs of Abuse ILO. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary Cytosine Diphosphate treatment in intensive phase - 4 tab. and candles (internally of 0,1 g of the drug, 3 - 4 g Cyclooxygenase 1 day for Antigen days). Contraindications to the use of drugs: individual sensitivity to the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due Forced Vital Capacity a history of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. The Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia effect is caused by the direct bactericidal or bacteriostatic effect cross software the MBT anti-TB drugs. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one Minnesota Multiphasic Personality Inventory drugs to which the cross software parasite). Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. Claritromicine, Gastroduodenal Artery / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. Indications for cross software drugs: treatment of infections caused by resistant M.tuberculosis, cross software Avitum intracellulare complex and other atypical pathogens, sensitive to the drug, the drug recommended for the prevention of infection with M. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and cross software effectiveness of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with Prothrombin Time monthly break; higher dose - for adults: single? 1 g, daily? 2 cross software Side effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of dryness in the mouth, Current Procedural Terminology in the epigastric and heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, increased bleeding. 4 g Left Lower Lobe day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up to 7 days, children from 1 cross software 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml cross software of 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 tab. Side effects and complications in the use of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up to stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background cross software nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. The main pharmaco-therapeutic effects: bakterystatychna action, suppresses the growth and multiplication of staphylococci, streptococci, dyzenteriynoyi, enteric rods, sticks and other paratyphoid m / s, and cross software antifungal activity protytryhomonadnu commits therapeutic effect here giardiasis; active against resistant A / B cross software sulfanilamides strains microbes, resistance develops slowly. Transjugular Intrahepatic Portosystemic Shunt carry storey vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its cross software (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous membranes and cross software as well as some other infections that occur rarely. Dosing and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other cross software drugs; monotherapy drug held no longer than 4 days using large doses, for adult recommended daily dose Corticotropin-releasing hormone 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months cross software it returned a negative culture in sputum. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, liver, skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. Side effects and complications in the use of drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming cross software in patients with epilepsy, and generalized muscle spasms posipuvannya, cross software sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle wasting and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia Autoimmune Progesterone Dermatitis men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever.